Why MannKind Stock Tumbled on Thursday
Mr. Market was hoping for a better fourth quarter than the company delivered. MannKind (MNKD 7.43%) was a stock to avoid on the second-to-last trading day of the week. Investors eagerly sold out of the commercial-stage biotech's equity, as they clearly …